EpigenCare

EpigenCare

Created using Figma
Created using Figma

Last Update

Mar 29, 2018

EpigenCare is connecting consumers with skincare companies through a direct-to-consumer skincare test and web platform on the Ethereum network. Consumers will be able to receive actionable recommendations of optimized skincare products to use, as well as assess the progress of their skincare routines, based on their skin's epigenetic profiles. A reward mechanism is implemented to encourage recurring tests and create transaction records on the blockchain ledger. This tokenization of data allows consumers to verify that their data is used solely for their own benefit in the structured ecosystem, solving the problem of perceived instrusiveness associated with personal tests requiring consumer DNA.
Sale
Apr 16, 2018
Jul 31, 2018
100% completed
Raised funds - no Data
past
Token Details
Ticker
EPIC
Accepted Currencies
ETH
Additional Details
Platform
Ethereum
KYC
Yes
Categories
Health

About EpigenCare

Scientifically Grounded

How does a consumer know whether a skincare product is truly working for them? EpigenCare is connecting consumers with skincare companies through a direct-to-consumer skincare test and web platform on the Ethereum network. Consumers will be able to receive actionable recommendations of optimized skincare products to use, as well as assess the progress of their skincare routines, based on their skin’s epigenetic profiles. The recommendation engine looks at the functional state of a panel of epigenetic markers strongly correlated with skin quality indicators (e.g., aging, moisture retention, elasticity, etc.), and how skincare product ingredients affect them.

 

A Cyclical Growth Ecosystem

As epigenetics regulates gene function and dynamically changes based on environment stimuli such as skincare product ingredients, it is a perfect fit for a recurring, tokenized business model. EpigenCare’s upcoming platform will be a structured ecosystem that allows skincare companies to target data segments with products that fulfill the recommendation engine’s matching requirements. Consumers that fall within the segment are rewarded with tokens, which can be used to subsidize additional tests (thereby generating additional advertising inventory for companies).

 

Disrupting the Skincare Industry

Our structured ecosystem allows for true leveraging of blockchain technology. The recurring nature of epigenetics allows for a perpetual incentivization model through data tokenization. By associating a transaction hash ID with each purchased test and data segment, we will be able to transparently prove that a consumer’s data is used only for their own benefit, thereby addressing the problem of perceived intrusiveness often associated with commercialized DNA-related testing. EpigenCare’s disruptive innovation introduces a new marketing channel to the $130 billion skincare industry and transform the way companies market their products to consumers through scientifically screened, individualized advertising.

 

Features

Offered under SEC Regulation CF, S, and D exemptions.

Technical Info

EpigenCare tokenizes data generated from their personal epigenomics system in a controlled ecosystem such that data movement is recorded on the blockchain ledger. Consumers can verify that their data was used directly for their own benefit in the form of a personalized product recommendation, and not through any other means. This solves the problem of perceived intrusiveness often associated with direct-to-consumer tests requiring consumer DNA.

EpigenCare Roadmap

  • Q2, 2017

  • EpigenCare Inc. Established in New York, USA
  • Q4 2017

  • Epigenetic-based Skincare Test Successfully Developed and Proven
  • Q4 2017

  • Epigenetic-based Skincare Test Successfully Developed and Proven
  • Q1 2018

  • ICO Token Generation Event
  • Read More
  • Q1 2018

  • ICO Token Generation Event
  • Q2 2018

  • Launch Marketing Campaign for Product Pre-Orders
  • Q3 2018

  • Limited Launch of Beta Skincare Test
  • Q4 2018

  • Full Skincare Test Launch to Public; Launch EpigenCare Network Open Beta
  • Q1 2019

  • Launch Consumer Mobile Application
  • Q2 2019

  • Launch Official EpigenCare Network Platform
  • Q2 2019

  • Launch Official EpigenCare Network Platform
  • Q3 2019

  • Retail Distribution Initiative; Deploy API (Application Programming Interface)
  • Q4 2019

  • Dermatologist/Spa/Beauty Salon Partnership Initiative
  • Future Objectives

  • Integrate Deep-Learning Artificial Intelligence Elements Based on Epigenetic Skin Data; Develop Complementary A-I-Based Mobile Imaging Application

Activity

Activity:
23
VERY LOW
Merit:
1
VERY LOW
Posts:
407
MEDIUM
Views:
7 428
HIGH
Users:
173
MEDIUM
Followers:
471
VERY LOW
Tweets:
117
MEDIUM
30 Days Growth:

EpigenCare Team

Verified 20%

Attention. There is a risk that unverified members are not actually members of the team

William Lee
Chief Executive Officer
verified
Adam Weiwei Li, Md,...
Chief Scientific Officer
unverified
Jessica Li
Chief Financial Officer
unverified
Ashley Pottash
Business Strategy Lead
unverified
Stephen Fiser
Software Development Lead
unverified

Advisors

Verified 0%

Attention. There is a risk that unverified members are not actually members of the team

Richard Wildnauer, P...
Business Advisor
unverified
James Wang, MD
Dermatology Advisor
unverified

7 ICO

$9 895 176

Brennan Bennett
Blockchain Advisor
unverified
Rebecca Fry
Epigenetics Advisor
unverified
Tim Bukher
Legal Strategy Advisor
unverified

EpigenCare Interviews

William Lee
As a team member, сan you tell us about your role in the ICO project? What do you think about idea?
CEO/Co-Founder
3.88
stable
5.0 17
ICO Profile Vision Activity Potential Product Team

EpigenCare Reviews

expert-coin.com
News, reviews

The strengths of the project:

Own scientific developments in the field of skincare;
Well thought-out concept of the product;
Clear understanding of the target audience;
Availability of a market niche for the product.

Weaknesses of the project:

There is no analysis of competitors;
Market analysis is very superficial.

Read More
  • Because there may be time differences in information updates, accurate information about each ICO project should be verified through its official website or other communication channels.
  • This information is not a suggestion or advice on investing in ICO funding. Please thoroughly investigate the relevant information yourself and decide on ICO participation.
  • If you think there are issues or problems to be corrected on this content, or if you would like to submit your own ICO project to be listed, Please email us.
Please read the disclaimer and risk warning. Show disclaimer and risk warning.
Planning an ICO? We can help with a wide range of support for all stages of your ICO